Contact this trialFirst, we need to learn more about you.
Alkylating Agent
Combination Therapy for Chronic Lymphocytic Leukemia
Recruiting1 awardPhase 2
Houston, Texas
This trial is testing a combination of drugs to treat chronic lymphocytic leukemia. Ibrutinib may stop cancer cell growth by blocking enzymes needed for cell growth. Fludarabine phosphate and cyclophosphamide work in different ways to stop cancer cell growth. Obinutuzumab may interfere with the ability of tumor cells to grow and spread. The combination of these drugs may work better to treat chronic lymphocytic leukemia.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service